Copyright Reports & Markets. All rights reserved.

Global Cardiology Point-of-Care (POC) Diagnostics Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Cardiology Point-of-Care (POC) Diagnostics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Cardiometabolic Monitoring
    • 1.4.3 Cardiometabolic Diagnostics
  • 1.5 Market by Application
    • 1.5.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Application: 2020 VS 2026
    • 1.5.2 Professional Diagnostic Centers
    • 1.5.3 Hospitals/Critical Care Centers
    • 1.5.4 Research Laboratories
    • 1.5.5 Home Care
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Cardiology Point-of-Care (POC) Diagnostics Growth Trends by Regions
    • 2.2.1 Cardiology Point-of-Care (POC) Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cardiology Point-of-Care (POC) Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Cardiology Point-of-Care (POC) Diagnostics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Cardiology Point-of-Care (POC) Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Cardiology Point-of-Care (POC) Diagnostics Players by Market Size
    • 3.1.1 Global Top Cardiology Point-of-Care (POC) Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Cardiology Point-of-Care (POC) Diagnostics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Cardiology Point-of-Care (POC) Diagnostics Market Concentration Ratio
    • 3.2.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Cardiology Point-of-Care (POC) Diagnostics Revenue in 2019
  • 3.3 Cardiology Point-of-Care (POC) Diagnostics Key Players Head office and Area Served
  • 3.4 Key Players Cardiology Point-of-Care (POC) Diagnostics Product Solution and Service
  • 3.5 Date of Enter into Cardiology Point-of-Care (POC) Diagnostics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Cardiology Point-of-Care (POC) Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2015-2020)
  • 5.2 Global Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cardiology Point-of-Care (POC) Diagnostics Market Size (2015-2020)
  • 6.2 Cardiology Point-of-Care (POC) Diagnostics Key Players in North America (2019-2020)
  • 6.3 North America Cardiology Point-of-Care (POC) Diagnostics Market Size by Type (2015-2020)
  • 6.4 North America Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size (2015-2020)
  • 7.2 Cardiology Point-of-Care (POC) Diagnostics Key Players in Europe (2019-2020)
  • 7.3 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size by Type (2015-2020)
  • 7.4 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2015-2020)

8 China

  • 8.1 China Cardiology Point-of-Care (POC) Diagnostics Market Size (2015-2020)
  • 8.2 Cardiology Point-of-Care (POC) Diagnostics Key Players in China (2019-2020)
  • 8.3 China Cardiology Point-of-Care (POC) Diagnostics Market Size by Type (2015-2020)
  • 8.4 China Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Cardiology Point-of-Care (POC) Diagnostics Market Size (2015-2020)
  • 9.2 Cardiology Point-of-Care (POC) Diagnostics Key Players in Japan (2019-2020)
  • 9.3 Japan Cardiology Point-of-Care (POC) Diagnostics Market Size by Type (2015-2020)
  • 9.4 Japan Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Market Size (2015-2020)
  • 10.2 Cardiology Point-of-Care (POC) Diagnostics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2015-2020)

11 India

  • 11.1 India Cardiology Point-of-Care (POC) Diagnostics Market Size (2015-2020)
  • 11.2 Cardiology Point-of-Care (POC) Diagnostics Key Players in India (2019-2020)
  • 11.3 India Cardiology Point-of-Care (POC) Diagnostics Market Size by Type (2015-2020)
  • 11.4 India Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Cardiology Point-of-Care (POC) Diagnostics Market Size (2015-2020)
  • 12.2 Cardiology Point-of-Care (POC) Diagnostics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Cardiology Point-of-Care (POC) Diagnostics Market Size by Type (2015-2020)
  • 12.4 Central & South America Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Siemens
    • 13.1.1 Siemens Company Details
    • 13.1.2 Siemens Business Overview
    • 13.1.3 Siemens Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.1.4 Siemens Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020))
    • 13.1.5 Siemens Recent Development
  • 13.2 Abbott
    • 13.2.1 Abbott Company Details
    • 13.2.2 Abbott Business Overview
    • 13.2.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.2.4 Abbott Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 13.2.5 Abbott Recent Development
  • 13.3 Roche
    • 13.3.1 Roche Company Details
    • 13.3.2 Roche Business Overview
    • 13.3.3 Roche Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.3.4 Roche Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 13.3.5 Roche Recent Development
  • 13.4 Opko
    • 13.4.1 Opko Company Details
    • 13.4.2 Opko Business Overview
    • 13.4.3 Opko Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.4.4 Opko Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 13.4.5 Opko Recent Development
  • 13.5 GE Healthcare
    • 13.5.1 GE Healthcare Company Details
    • 13.5.2 GE Healthcare Business Overview
    • 13.5.3 GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.5.4 GE Healthcare Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 13.5.5 GE Healthcare Recent Development
  • 13.6 Samsung Health
    • 13.6.1 Samsung Health Company Details
    • 13.6.2 Samsung Health Business Overview
    • 13.6.3 Samsung Health Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.6.4 Samsung Health Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 13.6.5 Samsung Health Recent Development
  • 13.7 BioMerieux
    • 13.7.1 BioMerieux Company Details
    • 13.7.2 BioMerieux Business Overview
    • 13.7.3 BioMerieux Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.7.4 BioMerieux Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 13.7.5 BioMerieux Recent Development
  • 13.8 Abbott
    • 13.8.1 Abbott Company Details
    • 13.8.2 Abbott Business Overview
    • 13.8.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.8.4 Abbott Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 13.8.5 Abbott Recent Development
  • 13.9 Terumo
    • 13.9.1 Terumo Company Details
    • 13.9.2 Terumo Business Overview
    • 13.9.3 Terumo Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.9.4 Terumo Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 13.9.5 Terumo Recent Development
  • 13.10 Accriva
    • 13.10.1 Accriva Company Details
    • 13.10.2 Accriva Business Overview
    • 13.10.3 Accriva Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 13.10.4 Accriva Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 13.10.5 Accriva Recent Development
  • 13.11 Akers
    • 10.11.1 Akers Company Details
    • 10.11.2 Akers Business Overview
    • 10.11.3 Akers Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 10.11.4 Akers Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 10.11.5 Akers Recent Development
  • 13.12 Radiometer
    • 10.12.1 Radiometer Company Details
    • 10.12.2 Radiometer Business Overview
    • 10.12.3 Radiometer Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 10.12.4 Radiometer Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 10.12.5 Radiometer Recent Development
  • 13.13 Response Biomedical
    • 10.13.1 Response Biomedical Company Details
    • 10.13.2 Response Biomedical Business Overview
    • 10.13.3 Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Introduction
    • 10.13.4 Response Biomedical Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2015-2020)
    • 10.13.5 Response Biomedical Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Cardiology Point-of-Care (POC) Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cardiology Point-of-Care (POC) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Siemens
    Abbott
    Roche
    Opko
    GE Healthcare
    Samsung Health
    BioMerieux
    Abbott
    Terumo
    Accriva
    Akers
    Radiometer
    Response Biomedical

    Market segment by Type, the product can be split into
    Cardiometabolic Monitoring
    Cardiometabolic Diagnostics
    Market segment by Application, split into
    Professional Diagnostic Centers
    Hospitals/Critical Care Centers
    Research Laboratories
    Home Care

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now